A Study of MM-111 and Paclitaxel with or without Trastuzumab in patients with Metastatic or Locally Advanced Cancer of the Esophagus, Gastroesophageal Junction and Stomach Estudio de MM-111 y paclitaxel con o sin trastuzumab en pacientes con carcinoma con cáncer de esófago, unión gastroesofágica o estómago con metastástasis o localmente avanzado The primary objective of the study is to compare the Progression Free Survival (PFS) between the experimental and comparator arms within two distinct patient populations: Patients with ?Traditional? ...

• Country None
• organs None
• Specialty None

A phase 2 study comparing MM-302 plus trastuzumab versus Chemotherapy of Physicians Choice plus trastuzumab in HER2+ metastatic breast cancer patients To determine whether the combination of MM-302 plus trastuzumab is more effective than chemotherapy of physician’s choice (CPC) plus trastuzumab based on progression free survival (PFS) as assessed by...

• Country None
• organs None
• Specialty None

A study of MM-398 with or without 5-Fluorouracil and Leucovorin compared with 5- Fluorouracil and Leucovorin in Patients with advanced pancreatic cancer who were previously treated unsuccessfully with a gemcitabine-based therapy To compare overall survival following treatment with MM-398, with orwithout 5-fluorouracil and leucovorin,versus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer that have ...

• Country None
• organs None
• Specialty None